Enanta Pharmaceuticals Inc.
ENTA | NASDAQ
$12.31
+$0.20 (+1.65%)
Sep 22, 2026, 1:23 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 14.36M | 17.16M | 18.62M | 15.13M | 18.31M | 14.93M | 16.96M | 14.61M | 17.97M | 17.05M | 18M | 18.93M | 18.89M | 17.8M | 23.59M | 20.32M | 19.48M | 18.72M | 27.65M | 23.58M | 21.62M | 20.13M | 31.74M |
Cost of Revenue | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 540K | 511K | 655K | 716K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 14.36M | 15.95M | 18.62M | 15.13M | 18.31M | 14.93M | 16.96M | 14.61M | 17.97M | 17.05M | 18M | 18.93M | 18.89M | 17.26M | 23.07M | 19.66M | 18.76M | 18.72M | 27.65M | 23.58M | 21.62M | 20.13M | 31.74M |
Operating Income | -17.24M | -11.85M | -11.25M | -18.39M | -18.89M | -24.53M | -23.54M | -29.85M | -24.19M | -32.77M | -34.89M | -31.03M | -36.71M | -39.45M | -30.01M | -27.05M | -32.54M | -33.85M | -30.41M | -33.73M | -33.85M | -29.7M | -12.3M |
Interest Income | n/a | 2.08M | 2.42M | 2.11M | 2.29M | 2.29M | 2.8M | 3.18M | 3.49M | 3.81M | 4.3M | 4.66M | 3.87M | 1.84M | 993K | 631K | 393K | 255K | 258K | 360K | 439K | 545K | 677K |
Pretax Income | -19.47M | -13.08M | -11.91M | -18.67M | -18.23M | -23.95M | -22.71M | -29.19M | -23.05M | -31.52M | -34.03M | -29.52M | -34.84M | -37.61M | -29.02M | -26.33M | -32.15M | -33.59M | -30.15M | -33.39M | -33.41M | -29.16M | -11.62M |
Net Income | -19.5M | -13.09M | -11.94M | -18.7M | -18.26M | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.07M | -37.66M | -28.99M | -26.35M | -31.7M | -33.59M | -30.12M | -24.6M | -24.02M | -22.05M | -8.33M |
Selling & General & Admin | 9.47M | 9.57M | 9.01M | 9.7M | 10M | 11.39M | 12.85M | 13.68M | 13.41M | 14.24M | 16.52M | 13.8M | 12.62M | 13.24M | 12.19M | 11.91M | 12.21M | 10.48M | 9.51M | 8.36M | 8.48M | 8.33M | 7.38M |
Research & Development | 22.13M | 19.44M | 20.86M | 23.81M | 27.21M | 28.07M | 27.66M | 30.78M | 28.74M | 35.59M | 36.37M | 36.17M | 42.99M | 43.47M | 40.9M | 34.8M | 39.09M | 42.09M | 48.55M | 48.95M | 46.99M | 41.51M | 36.67M |
Other Expenses | n/a | -1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 258K | n/a | n/a | n/a | n/a |
Operating Expenses | 31.6M | 27.8M | 29.87M | 33.51M | 37.21M | 39.45M | 40.5M | 44.46M | 42.16M | 49.82M | 52.89M | 49.96M | 55.61M | 56.71M | 53.09M | 46.71M | 51.3M | 52.56M | 58.06M | 57.3M | 55.47M | 49.83M | 44.04M |
Interest Expense | 4.13M | 3.32M | 3.08M | 2.39M | 1.62M | 1.71M | 1.96M | 2.58M | 2.36M | 2.56M | 3.44M | 3.15M | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 31.6M | 29.01M | 29.87M | 33.51M | 37.21M | 39.45M | 40.5M | 44.46M | 42.16M | 49.82M | 52.89M | 49.96M | 55.61M | 57.25M | 53.6M | 47.37M | 52.02M | 52.56M | 58.06M | 57.3M | 55.47M | 49.83M | 44.04M |
Income Tax Expense | 36K | 7K | 24K | 32K | 29K | -1.31M | -416K | -363K | -395K | -363K | -622K | -1.41M | 4.22M | 44K | -34K | 14K | -447K | n/a | -36K | -8.8M | -9.38M | -7.11M | -3.29M |
Shares Outstanding (Basic) | 29.09M | 29.04M | 28.75M | 21.38M | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.18M | 20.19M | 20.17M | 20.09M |
Shares Outstanding (Diluted) | 29.09M | 29.04M | 28.75M | 21.38M | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.22M | 20.2M | 20.17M | 20.09M |
EPS (Basic) | -0.67 | -0.45 | -0.42 | -0.87 | -0.86 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 | -1.79 | -1.39 | -1.28 | -1.53 | -1.63 | -1.48 | -1.22 | -1.19 | -1.09 | -0.41 |
EPS (Diluted) | -0.67 | -0.45 | -0.42 | -0.87 | -0.86 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 | -1.79 | -1.39 | -1.28 | -1.53 | -1.63 | -1.48 | -1.22 | -1.19 | -1.09 | -0.41 |
EBITDA | -15.34M | -8.56M | -7.6M | -15M | -15.4M | -21.03M | -19.86M | -26.13M | -20.1M | -28.34M | -29.95M | -25.7M | -32.2M | -37.07M | -28.51M | -25.68M | -31.43M | -32.77M | -29.37M | -32.59M | -32.59M | -28.87M | -11.43M |
EBIT | -15.34M | -9.77M | -8.83M | -16.28M | -16.61M | -22.24M | -20.74M | -26.61M | -20.7M | -28.96M | -30.59M | -26.37M | -32.85M | -37.61M | -29.02M | -26.33M | -32.15M | -33.59M | -30.15M | -33.39M | -33.41M | -29.7M | -12.3M |
Depreciation & Amortization | n/a | 1.21M | 1.23M | 1.28M | 1.21M | 1.2M | 889K | 479K | 594K | 621K | 642K | 669K | 651K | 540K | 511K | 655K | 716K | 822K | 780K | 806K | 823K | 834K | 871K |
Add to Watchlist
Select watchlists to add or remove ENTA